Abstract 14P
Background
Under the deep inspiration breath hold (DIBH) technique a considerable volume of the heart can be reduced to the high radiation doses. To investigate whether implementing DIBH to the hybrid technique will further reduce the cardiac doses, we compared the dosimetry characteristics of hybrid and VMAT treatment planning under DIBH and free breath.
Methods
Twenty patients with left-sided breast cancer who underwent breast-conserving surgery were selected for this study. Two sets of CT images were already acquired under deep-inspiration breath-hold (DIBH) and free-breathing(FB) before treatment. The same contours based on the original DIBH CT data sets were used for the modified Hybrid-technique and VMAT technique re-planning for the comparison of the original Hybrid planning. All plans were optimized to cover 100% of the PTV by 95% of the prescribed dose while minimizing the doses to the OAR as much as possible. The dosimetric differences among the 3 treatment plans for the 20 patients were analyzed using the Wilcoxon signed-rank test, the p value<0.05 were considered statistically significant. All analyses were performed using SPSS software, version 19.0.
Results
The mean heart dose was reduced from 3.2Gy and 5.38Gy, respectively (p value=0.002) and the LAD0.03cc dose was reduced from 14.85Gy and 24.91Gy, respectively (p value=0.001) by modified Hybrid-technique on DIBH and FB conditions. No statistically significant dose difference (p value>0.05) was found in the tumor conformity and homogeneity, and the critical organ on the affected side by the modified Hybrid-technique of VMAT under DIBH. In the contralateral critical organ, the modified Hybrid-tech showed better dose sparing than VMAT on the average dose of the contralateral lung, and the average dose of the contralateral breast.
Conclusions
Modified Hybrid-technique provides the best benefits for heart and OAR radiation dose sparing effect on DIBH condition.
Clinical trial identification
This clinical trial is approved by the institution review board of Taichung Veterans General Hospital (CE21447B).
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
6P - Deep learning radiomics supports perioperative treatment decisions and is associated with LncRNAs in breast cancer: A multicenter study
Presenter: Yunfang Yu
Session: Poster viewing 01
7P - Predicting lymph node metastasis and molecular subtype from pathology united with genomics in breast cancer with multitask deep learning
Presenter: Zehua Wang
Session: Poster viewing 01
8P - Dismantling the role of liquid biopsy in predicting outcome of patients with early-stage breast cancer following neoadjuvant therapy: A systematic review
Presenter: Jeremiah Wijaya
Session: Poster viewing 01
9P - Development and validation of a pathogenomics model to improve the risk stratification of breast cancer: A deep learning study
Presenter: lin ruichong
Session: Poster viewing 01
10P - Enriched gut microbiota increases anticancer drug efficacy in breast cancer cell lines: A promising in vitro approach
Presenter: Selvaraj Jayaraman
Session: Poster viewing 01
11P - Preservation of intercostobrachial nerve during axillary lymph node dissection in breast cancer patients positively impacts chronic pain, sensory changes, and quality of life: Should it be the standard?
Presenter: Ajai Sasidhar
Session: Poster viewing 01
12P - Non-clinical factors influencing patient’s choice of mastectomy over breast conservation among Indian women with breast cancer
Presenter: Nivedita Sharma
Session: Poster viewing 01
13P - Hypofractionated radiotherapy in post operative breast cancer patients: 3-year clinical experience in a newly established cancer center
Presenter: Shaila Sharmin
Session: Poster viewing 01
15P - Delays in breast cancer treatment in a tertiary hospital
Presenter: Rogelio Velasco
Session: Poster viewing 01
16P - The prognostic value of androgen receptor expression in triple-negative breast cancer patients
Presenter: Rasha Haggag
Session: Poster viewing 01